Stefan Kaufmann Advocates for Advancements in Tuberculosis Control

Renowned vaccine researcher, Prof. Dr. Stefan H. E. Kaufmann, recently shared his expertise and insights on tuberculosis in an exclusive interview with ETHealthworld. Prof. Dr. Kaufmann, the inventor of VPM1002, highlighted the urgent need for better TB vaccines and advancements in novel drug regimens to combat this global health challenge. Here is the link to his interview.

We are honored to introduce Prof. Dr. Kaufmann as the keynote lecturer at the 14th International VPM Days, taking place on September 28th and 29th at TWINCORE in Hannover. This event serves as a unique opportunity to learn from one of the foremost experts in the field and connect with like-minded professionals and researchers.

Register now via email to: to secure your spot.